Search results for: Precision Medicine
Filter search results
The Future of Global Health Procurement: Issues around Pricing Transparency
1 March 2019
…of medicines by Middle and Low Income Countries. Will making prices publicly available make procurement more efficient and cost-effective medicines more accessible? This OHE Research Paper focuses on the role…
Is collaboration between and across regulatory and HTA agencies the answer to access challenges?
12 November 2024
…timely development of medicines and provide earlier patient access to truly innovative medicines, by pulling together expertise from across the MHRA and partners in the wider healthcare system including NICE,…
Projecting Expenditure on Medicines in the NHS: Second Edition
1 January 2014
…of the five-year deal between the pharmaceuctical industry and the government in the UK. For the first time, the PPRS caps future growth in the NHS’s branded medicines bill, between…
Without Prescription: a Study of the Role of Self-Medication
1 July 1968
The total expenditure on medicines in the United Kingdom in 1966 was £267 million. Of this £188 million was for medicines prescribed on the National Health Service. The other £79…
Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience
1 February 2009
Lower usage of cancer medicines in the UK compared to other countries has created questions, including whether the current approach by NICE to assessing cancer medicines is an important factor…
Making Outcome-Based Payment a Reality in the NHS
2 January 2019
…payment mechanism – outcome-based payment (OBP) – for cancer medicines into the NHS in England. This model links the price the NHS pays for a medicine to the outcomes it…
Narrowing the Gap between provision and need for medicines in developing countries
1 February 2000
…need and the probability of success (a function of the state of science, in-house resources and experience and risk). As the expected number of patients able to pay for medicines…
Overview of the Economics of the Market for Medicines in the UK
29 March 2012
…the economics of the market for medicines in the UK. OHE’s Dr Jorge Mestre-Ferrandiz is a visiting lecturer in the Department of Economics at City University London. As part of…
Future UK Medicines Spending: Four Nation Analysis
31 October 2012
In July, OHE released projections for medicines spending in the UK NHS for 2012‒2015. We have now completed further projections, also for the ABPI, for each of the four UK…